OS Therapies Inc

Research OS Therapies Inc (OSTX) on Bullrun: market cap USD 99.77M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOSTX
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 99.77M
• Financial periodFY2025
• Net income-USD 28.75M
• Free cash flow-USD 14.70M

Valuation Snapshot

latest market cap is USD 99.77M.

About OS Therapies Inc

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers.

Frequently asked questions

What is OS Therapies Inc's market cap?

OS Therapies Inc's market capitalization is USD 99.77M.

What does OS Therapies Inc do?

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.